http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93a307f00f56f8780bbc4a03b3a808b7
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Zhu |
| name | Zhenping Zhu |
| given-name | Zhenping |
| organization-name | 4ImClone Systems, New York, New York; and 1Antibody Technology, Departments of Novartis Institutes for Biomedical Research, Cambridge, MA 02139; and Division of Hematology-Oncology, Weill Medical College of Cornell University, New York, NY 10021; ImClone Systems Incorporated, New York, NY 10014; Sloan-Kettering Institute for Cancer Research, New York, NY 10021; and Sapporo City General Hospital, 060-8604 Sapporo, Japan From the Laboratory of Angiogenesis Research, Microbiology and Tumor Biology Center, Karolinska Institutet, Stockholm, Sweden; Department of Biochemistry, Faculty of Medicine, University of Hong Kong; and ImClone Systems, New York, NY. 4ImClone Systems, New York, NY 10014 Contribution from the State Key Laboratory of Coal Conversion, Institute of Coal Chemistry, Chinese Academy of Sciences, Taiyuan 030001, People's Republic of China, and Graduate School of Chinese Academy of Sciences, Beijing 100039, People's Republic of China ImClone Systems Incorporated, 108 Varick Street, New York, NY 10014; From the Department of Neurology (J.C., Z.G.Z., Y.L., L.W., M.C.), Division of Hematology/Oncology (Y.X.X., S.C.G.), Biostatistics and Research Epidemiology (M.L.), Henry Ford Health Sciences Center, Detroit, Mich; the Department of Antibody Technology (Z.Z.), ImClone Systems Incorporated, New York, NY; and the Department of Physics (M.C.), Oakland University, Rochester, Mich. State Key Laboratory of Coal Conversion; Institute of Coal Chemistry; Chinese Academy of Sciences; Taiyuan 030001; China eImClone Systems Inc., New York, New York 10014 3ImClone Systems Incorporated, New York, New York State Key Laboratory of Coal Conversion, Institute of Coal Chemistry, Chinese Academy of Sciences, Taoyuan South Road 27, Taiyuan, 030001 China Department of Antibody and Protein Engineering, 3sBio Inc, Pudong, Shanghai, China State Key Laboratory of Coal Conversion Institute of Coal Chemistry Chinese Academy of Sciences Taiyuan 030001 China ImClone Systems, New York, NY; 4ImClone Systems, Inc., New York, New York From the Johns Hopkins University School of Medicine, Oncology, Pediatrics, Baltimore, MD; the Department of Hematology, Hospital Saint-Antoine, Paris, France; the Department of Leukemia, MD Anderson Cancer Center, Houston, TX; and ImClone Systems, Inc, New York, NY. Research and development, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. A 3SBio Inc. Company, Shanghai, China From ImClone Systems Incorporated, New York, NY; and the Department of Biochemistry and Molecular Biophysics, Columbia University College of Physicians and Surgeons, New York, NY. 3ImClone Systems, Inc., New York, New York ImClone Systems Incorporated, 180 Varick Street, New York, NY 10014, USA Authors' Affiliations: Departments of 1Antibody Technology & Immunology, 2Cell Biology, 3Preclinical Pharmacology, 4Molecule and Cell Engineering, 5Protein Science, 6Clinical Research, and 7Research, ImClone Systems, New York, New York From the Laboratory of Developmental Hematopoiesis/Cell Biology Program, the Department of Medicine, and the Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY; and ImClone Systems, New York, NY. From the Angiogenesis Laboratory, Centro Investigação Patobiologia Molecular, Instituto Português de Oncologia Francisco Gentil (IPOFG), Lisboa, Portugal; the Serviço de Anatomia Patológica, IPOFG, Lisboa, Portugal; the Instituto de Medicina Molecular (IMM), Faculdade de Medicina, Lisboa, Portugal; the Instituto Gulbenkian de Ciência, Oeiras, Portugal; and ImClone Systems, New York, NY. State Key Laboratory of Coal Conversion, Institute of Coal Chemistry, Chinese Academy of Sciences, Taiyuan, 030001 China State Key Laboratory of Coal Conversion, Institute of Coal Chemistry, Chinese Academy of Sciences, Taiyuan, Shanxi 030001, China ImClone Systems Incorporated New York New York Department of Molecular and Cell Biology, ImClone Systems, New York, NY 10014 From ImClone Systems, New York, NY; and the Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD. State Key Laboratory of Coal Conversion Institute of Coal Chemistry Chinese Academy of Sciences 030001 Taiyuan China ImClone Systems Incorporated, New York, New York From the Department of Neurology (R.Z., L.W., L.Z., J.C., Z. Zhang, M.C.), Henry Ford Health Sciences Center, Detroit, Mich; the Department of Antibody Technology (Z. Zhu), ImClone Systems Incorporated, New York, NY; and the Department of Physics (M.C.), Oakland University, Rochester, Mich. 4ImClone Systems, New York, New York Departments of Antibody Technology and Protein Science, ImClone Systems, New York, New York State Key Laboratory of Coal Conversion, Institute of Coal Chemistry, Chinese Academy of Sciences, Taiyuan 030001, China ImClone Systems Inc, Department Antibody Technology, 180 Varick Street, NY 10014, USA. [email protected] Authors' Affiliations: 1Angiogenesis Group, Instituto Português de Oncologia Franscisco Gentil de Lisboa, EPE (CIPM/IPOLFG), Lisbon; 2Neoangiogenesis Group, Instituto Gulbenkian de Ciência, Oeiras; 3CEDOC, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal; and 4Imclone Systems, New York. 2Antibody Engineering, ImClone Systems Incorporated, New York, NY 10014 Institute of Coal Chemistry, Chinese Academy of Science, Taiyuan 030001, P. R. China From the Division of Hematology-Oncology, Weill Medical College of Cornell University, New York, NY; Division of Molecular, Cell Biology and Immunology, ImClone Systems, New York, NY; Department of Cardiothoracic Surgery, Columbia-Presbyterian Medical Center, New York, NY; and Division of Developmental Hematopoiesis, Sloan Kettering Cancer Center, New York, NY. 1 ImClone Systems Incorporated, New York, NY 10014, USA |
Incoming Links
Showing number of triples: 1 to 201 of 201.